CiproPAL is a randomised,open-label trial in paediatric patients (1-17 years inclusive) with de-novo Acute Lymphoblastic Leukaemia treated on the existing ALLTogether-1 study (EudraCT 2018-001795-38,REC ref 20/LO/0848,Sponsor: Karolinska University) in the UK. The two main aims of the CiproPAL trial are: 1. To assess the efficacy of ciprofloxacin prophylaxis in reducing infections during the induction phase of the ALLTogether1 Trial. 2. To evaluate the impact of ciprofloxacin prophylaxis on antimicrobial resistance,both in terms of invasive infections and colonising organisms. Patients will be randomised (1:1) ...

GO TO STUDY

This is a study of an investigational new drug device combination product of Staccato and alprazolam inhalation powder, called “Staccato® alprazolam”. Staccato alprazolam is a single-use, hand-held, portable device that delivers alprazolam in aerosol form (a fine spray) deep into the lungs through inhalation (breathing in). Alprazolam is a drug which acts on the brain and nerves to produce a calming effect. The purpose of this study is to assess the effect and safety of Staccato alprazolam in epilepsy patients with ...

GO TO STUDY

The retina is the light-sensitive nerve layer that lines the inside of the back of the eye and converts light into electrical signals that is transmitted to the brain via the optic nerve. Inherited retinal diseases (IRDs) are characterised by retinal degeneration associated with genetic mutations. IRDs can affect individuals at any age and progress at different rates with worsening sight or blindness over time. The blinding nature of IRDs, lack of treatment, and complex heterogeneity associated to these conditions ...

GO TO STUDY

Around a quarter of patients with the most common cause of thyroid gland overactivity (Graves' disease) develop a complication known as Graves' orbitopathy (GO). In GO, tissues in the space behind the eyeballs (the orbit) become inflamed, causing pressure to build up. This causes intense pain, restriction of eye movements, and in some cases permanent damage to sight. The pressure causes the eyeballs to bulge forward (proptosis), causing a startled, staring appearance which is disfiguring and a cause of great ...

GO TO STUDY

The centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for reading and recognising faces. These cells can be damaged by a disease called wet age-related macular degeneration (AMD), where new abnormal blood vessels grow through the macula and leak fluid. This can affect vision. In some cases, wet AMD can also cause a bleed under the macula, known as a submacular haemorrhage (SMH), which can lead ...

GO TO STUDY

This is a non-therapeutic experimental pilot study which aims to recruit up to 19 patients within England. Participants will be identified and approached by a healthcare professional that is part of their clinical care team within the haematology department at Churchill Hospital,Oxford. This study aims to develop 89Zr-belantamab as a PET imaging agent to image BCMA on myeloma cell infiltration. If the imaging agent can reliably demonstrate myeloma deposits,it has several potential applications for drug development and clinical ...

GO TO STUDY

RESEARCH QUESTION: In post-menopausal women who will not require chemotherapy for >T1,strongly ER+,HER2- invasive breast cancer,does NET improve global HRQoL over 15 months and increase breast BCS rates? Patients will be randomised 1:1 to either the intervention (NET) arm (6 +/- 1 months of NET followed by surgery and adjuvant ET) or the control arm (2-4 weeks of presurgical NET and surgery within 2-4 weeks [up to 8 weeks permitted for trial purposes] followed by adjuvant ET). Both arms will receive ...

GO TO STUDY

The research methodology is based on a single centre observational cohort study,with an internal blinded comparison where each patient acts as their own control. The study is based on the premise of achieving high dimensional prospective data collection in a sufficient number of patients to allow for credible and comprehensive evaluation of the scope of the precision approach and its cost-effectiveness in a specified context of rare cancers. The participants are managed entirely by the standard of care pathway,but consents are obtained ...

GO TO STUDY

The lack of effective treatments for dementia remains one of the key challenges to modern medicine and society. Its leading cause is Alzheimer’s disease (AD), a condition where proteins (called amyloid and tau) build up in the brain causing inflammation and loss of nerve cells. Importantly, we now know that this process begins decades before first symptoms of dementia appear offering an opportunity to stop it in its tracks with the right treatment. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a ...

GO TO STUDY

Every year, over one million people in England and Wales suffer a mild Traumatic Brain Injury (TBI) needing hospital care. Bleeding into the brain is a common and serious complication of TBI and older adults are at highest risk. Even a small bleed into the brain can cause disability and some patients can die if the bleeding is more severe. We know that giving a drug called tranexamic acid as an infusion into the vein after a TBI reduces the ...

GO TO STUDY